Detalhe da pesquisa
1.
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer.
N Engl J Med
; 389(16): 1453-1465, 2023 Oct 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37851874
2.
Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer.
N Engl J Med
; 382(23): 2197-2206, 2020 06 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32469184
3.
Nadir Prostate-specific Antigen as an Independent Predictor of Survival Outcomes: A Post Hoc Analysis of the PROSPER Randomized Clinical Trial.
J Urol
; 209(3): 532-539, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36756959
4.
Plain language summary: Can declines in prostate-specific antigen level indicate how long patients with advanced prostate cancer will live when treated with enzalutamide?
Future Oncol
; 19(29): 1953-1960, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37585665
5.
Which traits affect how long patients with advanced prostate cancer live when treated with enzalutamide?
Future Oncol
; 18(35): 3867-3874, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-36226865
6.
The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer.
Breast Cancer Res Treat
; 187(1): 155-165, 2021 May.
Artigo
Inglês
| MEDLINE | ID: mdl-33591468
7.
First-in-human evaluation of the novel mitochondrial complex I inhibitor ASP4132 for treatment of cancer.
Invest New Drugs
; 39(5): 1348-1356, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33830407
8.
Enzalutamide with androgen deprivation therapy in Japanese men with metastatic hormone-sensitive prostate cancer: A subgroup analysis of the phase III ARCHES study.
Int J Urol
; 28(7): 765-773, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33955599
9.
A pharmacokinetic and pharmacodynamic comparison of immediate-release metoprolol and extended-release metoprolol CR/XL in patients with suspected acute myocardial infarction: a randomized, open-label study.
Cardiology
; 127(2): 73-82, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24247812
10.
Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial.
Ann Intern Med
; 156(6): 405-15, 2012 Mar 20.
Artigo
Inglês
| MEDLINE | ID: mdl-22431673
11.
Enzalutamide versus bicalutamide in patients with nonmetastatic castration-resistant prostate cancer: a prespecified subgroup analysis of the STRIVE trial.
Prostate Cancer Prostatic Dis
; 25(2): 363-365, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34621011
12.
Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER.
Eur J Cancer
; 170: 285-295, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35643841
13.
A phase 3 randomised study of enzalutamide plus leuprolide and enzalutamide monotherapy in high-risk non-metastatic hormone-sensitive prostate cancer with rising PSA after local therapy: EMBARK study design.
BMJ Open
; 11(8): e046588, 2021 08 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34385241
14.
Consistent survival benefit of enzalutamide plus androgen deprivation therapy in men with nonmetastatic castration-resistant prostate cancer: PROSPER subgroup analysis by age and region.
Eur J Cancer
; 159: 237-246, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34784577
15.
Prostate-specific Antigen Progression in Enzalutamide-treated Men with Nonmetastatic Castration-resistant Prostate Cancer: Any Rise in Prostate-specific Antigen May Require Closer Monitoring.
Eur Urol
; 78(6): 847-853, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33010985
16.
Association Between New Unconfirmed Bone Lesions and Outcomes in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide: Secondary Analysis of the PREVAIL and AFFIRM Randomized Clinical Trials.
JAMA Oncol
; 6(2): 217-225, 2020 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31830211
17.
ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer.
J Clin Oncol
; 37(32): 2974-2986, 2019 11 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31329516
18.
Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial.
Circulation
; 116(1): 49-56, 2007 Jul 03.
Artigo
Inglês
| MEDLINE | ID: mdl-17576868
19.
Efficacy, safety, and pharmacokinetics of candesartan cilexetil in hypertensive children aged 6 to 17 years.
J Clin Hypertens (Greenwich)
; 10(10): 743-50, 2008 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-19090875
20.
Efficacy and safety of extended release metoprolol succinate in hypertensive children 6 to 16 years of age: a clinical trial experience.
J Pediatr
; 150(2): 134-9, 139.e1, 2007 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-17236889